A Study of Disease Progression and Anti-HIV Treatments
Completed · Phase 2
Conditions studied: HIV Infections
In brief
To determine the influence of virus load, CD4 count, biologic phenotype, and presence of symptomatic disease on the response of HIV-infected patients to a new therapeutic regimen. PER AMENDMENT 8/27/96: To extend the availability of currently assigned ACTG 303 treatment for 6 months.
Key facts
- Study ID
- NCT00001068
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 210
- Expected to finish
- 1998-10-01
- Last updated by the study team
- 2021-11-04
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must have:
- Prior participation on protocol ACTG 175.
- PER AMENDMENT 8/27/96:
- Patients must be on study/on treatment at the time the protocol study treatment is extended.
Where it is running
- Alabama Therapeutics CRS — Birmingham, Alabama, United States
- USC CRS — Los Angeles, California, United States
- UCLA CARE Center CRS — Los Angeles, California, United States
- Stanford CRS — Palo Alto, California, United States
- Ucsd, Avrc Crs — San Diego, California, United States
- Ucsf Aids Crs — San Francisco, California, United States
- Santa Clara Valley Med. Ctr. — San Jose, California, United States
- San Mateo County AIDS Program — Stanford, California, United States
- Harbor-UCLA Med. Ctr. CRS — Torrance, California, United States
- University of Colorado Hospital CRS — Aurora, Colorado, United States
- Univ. of Miami AIDS CRS — Miami, Florida, United States
- Emory Univ. Hemophilia Program Office — Atlanta, Georgia, United States
- Northwestern University CRS — Chicago, Illinois, United States
- Cook County Hosp. CORE Ctr. — Chicago, Illinois, United States
- Rush Univ. Med. Ctr. ACTG CRS — Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic — Indianapolis, Indiana, United States
- Tulane Hemophilia Treatment Ctr. — New Orleans, Louisiana, United States
- Johns Hopkins Adult AIDS CRS — Baltimore, Maryland, United States
- Massachusetts General Hospital ACTG CRS — Boston, Massachusetts, United States
- Bmc Actg Crs — Boston, Massachusetts, United States
- Beth Israel Deaconess - East Campus A0102 CRS — Boston, Massachusetts, United States
- Beth Israel Deaconess Med. Ctr., ACTG CRS — Boston, Massachusetts, United States
- University of Minnesota, ACTU — Minneapolis, Minnesota, United States
- St. Louis ConnectCare, Infectious Diseases Clinic — St Louis, Missouri, United States
- Washington U CRS — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.